Concepedia

Zhenbo Hu

ZH

Statistics

Publications

45

Citations

2.1K

H-Index

28

Active since

1993

Affiliations

Weifang Medical University(Current)

Cleveland Clinic

Leibniz Institute DSMZ – German Collection of Microorganisms and Cell Cultures

Ontario Institute for Cancer Research

Case Western Reserve University

Zhenbo Hu is an author at Weifang Medical University specializing in life sciences, molecular biology, and molecular oncology.

ORCID

Publications per year

1993–2024

45

Publications

45

Human biliverdin reductase: A member of the insulin receptor substrate family with serine/threonine/tyrosine kinase activity

Nicole Lerner‐Marmarosh, Jenny Y. Shen, Michael D. Torno et al. · Proceedings of the National Academy of Sciences · 2005 · 155 citations · Full text

, , +14

Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies

Shahper N. Khan, A. Jankowska, Reda Z. Mahfouz et al. · Leukemia · 2013 · 129 citations

, , +17

Leukemogenic nucleophosmin mutation disrupts the transcription factor hub that regulates granulomonocytic fates

Xiaorong Gu, Quteba Ebrahem, Reda Z. Mahfouz et al. · Journal of Clinical Investigation · 2018 · 117 citations · Full text

, , +14

Biliverdin Reductase, a Novel Regulator for Induction of Activating Transcription Factor-2 and Heme Oxygenase-1

Anatoliy Kravets, Zhenbo Hu, Tihomir Miralem et al. · Journal of Biological Chemistry · 2004 · 104 citations · Full text

, , +14

Histone demethylase KDM3B protects against ferroptosis by upregulating SLC7A11

Yishu Wang, Yao Zhao, Haihua Wang et al. · FEBS Open Bio · 2020 · 101 citations · Full text

, , +14

1–5 of 45